By Lívia Honório de Figueiredo
February 14, 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.
Last by Lívia Honório de Figueiredo
May 4, 2023
Kasznar Leonardos attends the BIO International Convention
Our specialists Lívia Figueiredo and Jansen Viana are set to attend the BIO International Convention, which will take place from June 5-8, 2023, … Kasznar Leonardos attends the BIO International Convention
April 24, 2023
“Brazil: The patent combination conundrum” for LSIPR Magazine
Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine
December 28, 2022
BPTO publishes phase IV of the Patent Prosecution Highway (PPH) Program
The Brazilian Patent and Trademark Office (BPTO) published, by means of Ordinance n° 78, dated December 16th 2022, phase IV of the Patent … BPTO publishes phase IV of the Patent Prosecution Highway (PPH) Program